Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies David Alan Campbell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Hollman Meyer - $711K of JANX open-market activity in the last 12 months
- Janeen Noel Doyle - $57K of JANX open-market activity in the last 12 months
- Maria Dobek - $29K of JANX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David Alan Campbell?
David Alan Campbell is a corporate insider, tracked as President and CEO, Director of Janux Therapeutics, Inc. (JANX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Alan Campbell submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has David Alan Campbell been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($5.04M) across all tracked filings.
Where can I see all of David Alan Campbell's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David Alan Campbell and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
